nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrosine—TH—cervicothoracic ganglion—systemic scleroderma	0.468	0.799	CbGeAlD
Metyrosine—TH—artery—systemic scleroderma	0.0478	0.0815	CbGeAlD
Metyrosine—TH—blood vessel—systemic scleroderma	0.0372	0.0635	CbGeAlD
Metyrosine—Hypervigilance—Methotrexate—systemic scleroderma	0.0302	0.0729	CcSEcCtD
Metyrosine—Salivation—Pentoxifylline—systemic scleroderma	0.021	0.0508	CcSEcCtD
Metyrosine—TH—connective tissue—systemic scleroderma	0.0191	0.0325	CbGeAlD
Metyrosine—TH—digestive system—systemic scleroderma	0.0138	0.0235	CbGeAlD
Metyrosine—Speech impairment NOS—Methotrexate—systemic scleroderma	0.00995	0.0241	CcSEcCtD
Metyrosine—Salivary hypersecretion—Pentoxifylline—systemic scleroderma	0.00792	0.0191	CcSEcCtD
Metyrosine—Swelling—Pentoxifylline—systemic scleroderma	0.00671	0.0162	CcSEcCtD
Metyrosine—Nasal congestion—Pentoxifylline—systemic scleroderma	0.0065	0.0157	CcSEcCtD
Metyrosine—Thrombocytosis—Mycophenolate mofetil—systemic scleroderma	0.00617	0.0149	CcSEcCtD
Metyrosine—Blood disorder—Leflunomide—systemic scleroderma	0.0061	0.0147	CcSEcCtD
Metyrosine—Blood disorder—Mycophenolic acid—systemic scleroderma	0.00582	0.0141	CcSEcCtD
Metyrosine—Nasal congestion—Mometasone—systemic scleroderma	0.00561	0.0136	CcSEcCtD
Metyrosine—Blood disorder—Mycophenolate mofetil—systemic scleroderma	0.00459	0.0111	CcSEcCtD
Metyrosine—Speech disorder—Mycophenolate mofetil—systemic scleroderma	0.00446	0.0108	CcSEcCtD
Metyrosine—Salivary hypersecretion—Lisinopril—systemic scleroderma	0.00425	0.0103	CcSEcCtD
Metyrosine—Swelling—Mycophenolic acid—systemic scleroderma	0.004	0.00967	CcSEcCtD
Metyrosine—Eosinophilia—Captopril—systemic scleroderma	0.00384	0.00928	CcSEcCtD
Metyrosine—Erectile dysfunction—Captopril—systemic scleroderma	0.00357	0.00863	CcSEcCtD
Metyrosine—Nasal congestion—Lisinopril—systemic scleroderma	0.00349	0.00843	CcSEcCtD
Metyrosine—Tremor—Pentoxifylline—systemic scleroderma	0.00334	0.00807	CcSEcCtD
Metyrosine—Anaemia—Pentoxifylline—systemic scleroderma	0.0033	0.00797	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Mycophenolic acid—systemic scleroderma	0.00318	0.00768	CcSEcCtD
Metyrosine—Eosinophilia—Leflunomide—systemic scleroderma	0.00317	0.00765	CcSEcCtD
Metyrosine—Hallucination—Captopril—systemic scleroderma	0.00309	0.00747	CcSEcCtD
Metyrosine—Anxiety—Pentoxifylline—systemic scleroderma	0.00303	0.00731	CcSEcCtD
Metyrosine—Dysuria—Leflunomide—systemic scleroderma	0.00299	0.00722	CcSEcCtD
Metyrosine—Dry mouth—Pentoxifylline—systemic scleroderma	0.00297	0.00718	CcSEcCtD
Metyrosine—Confusional state—Pentoxifylline—systemic scleroderma	0.00293	0.00709	CcSEcCtD
Metyrosine—Dysuria—Mycophenolic acid—systemic scleroderma	0.00285	0.00689	CcSEcCtD
Metyrosine—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00285	0.00689	CcSEcCtD
Metyrosine—Erectile dysfunction—Mycophenolic acid—systemic scleroderma	0.00281	0.00679	CcSEcCtD
Metyrosine—Eosinophilia—Lisinopril—systemic scleroderma	0.00272	0.00657	CcSEcCtD
Metyrosine—Haematuria—Leflunomide—systemic scleroderma	0.00272	0.00657	CcSEcCtD
Metyrosine—Insomnia—Pentoxifylline—systemic scleroderma	0.00263	0.00636	CcSEcCtD
Metyrosine—Haematuria—Mycophenolic acid—systemic scleroderma	0.00259	0.00627	CcSEcCtD
Metyrosine—Dysuria—Lisinopril—systemic scleroderma	0.00257	0.00621	CcSEcCtD
Metyrosine—Dry mouth—Mometasone—systemic scleroderma	0.00256	0.00619	CcSEcCtD
Metyrosine—Erectile dysfunction—Lisinopril—systemic scleroderma	0.00253	0.00611	CcSEcCtD
Metyrosine—Speech disorder—Methotrexate—systemic scleroderma	0.00253	0.00611	CcSEcCtD
Metyrosine—Oedema peripheral—Leflunomide—systemic scleroderma	0.00252	0.00609	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Mycophenolate mofetil—systemic scleroderma	0.00251	0.00606	CcSEcCtD
Metyrosine—Anaemia—Captopril—systemic scleroderma	0.0025	0.00604	CcSEcCtD
Metyrosine—Hallucination—Mycophenolic acid—systemic scleroderma	0.00243	0.00587	CcSEcCtD
Metyrosine—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.0024	0.00581	CcSEcCtD
Metyrosine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.0024	0.0058	CcSEcCtD
Metyrosine—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00238	0.00575	CcSEcCtD
Metyrosine—Haematuria—Lisinopril—systemic scleroderma	0.00234	0.00564	CcSEcCtD
Metyrosine—Urticaria—Pentoxifylline—systemic scleroderma	0.00231	0.00559	CcSEcCtD
Metyrosine—Abdominal pain—Pentoxifylline—systemic scleroderma	0.0023	0.00556	CcSEcCtD
Metyrosine—Dysuria—Mycophenolate mofetil—systemic scleroderma	0.00225	0.00544	CcSEcCtD
Metyrosine—Dry mouth—Captopril—systemic scleroderma	0.00225	0.00544	CcSEcCtD
Metyrosine—Confusional state—Captopril—systemic scleroderma	0.00222	0.00537	CcSEcCtD
Metyrosine—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.00222	0.00536	CcSEcCtD
Metyrosine—Hallucination—Lisinopril—systemic scleroderma	0.00219	0.00529	CcSEcCtD
Metyrosine—Anaemia—Azathioprine—systemic scleroderma	0.00218	0.00527	CcSEcCtD
Metyrosine—Oedema peripheral—Lisinopril—systemic scleroderma	0.00217	0.00523	CcSEcCtD
Metyrosine—Fatigue—Mometasone—systemic scleroderma	0.00217	0.00523	CcSEcCtD
Metyrosine—Thrombocytopenia—Captopril—systemic scleroderma	0.00216	0.00522	CcSEcCtD
Metyrosine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00214	0.00518	CcSEcCtD
Metyrosine—Asthenia—Pentoxifylline—systemic scleroderma	0.00209	0.00505	CcSEcCtD
Metyrosine—Anaemia—Leflunomide—systemic scleroderma	0.00206	0.00498	CcSEcCtD
Metyrosine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00205	0.00496	CcSEcCtD
Metyrosine—Haematuria—Mycophenolate mofetil—systemic scleroderma	0.00205	0.00494	CcSEcCtD
Metyrosine—Insomnia—Captopril—systemic scleroderma	0.00199	0.00482	CcSEcCtD
Metyrosine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00199	0.00481	CcSEcCtD
Metyrosine—Tremor—Mycophenolic acid—systemic scleroderma	0.00199	0.00481	CcSEcCtD
Metyrosine—Abdominal pain—Mometasone—systemic scleroderma	0.00199	0.0048	CcSEcCtD
Metyrosine—Anaemia—Mycophenolic acid—systemic scleroderma	0.00196	0.00475	CcSEcCtD
Metyrosine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.00192	0.00463	CcSEcCtD
Metyrosine—Fatigue—Captopril—systemic scleroderma	0.0019	0.0046	CcSEcCtD
Metyrosine—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.0019	0.00459	CcSEcCtD
Metyrosine—Anxiety—Leflunomide—systemic scleroderma	0.00189	0.00457	CcSEcCtD
Metyrosine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00188	0.00455	CcSEcCtD
Metyrosine—Dry mouth—Leflunomide—systemic scleroderma	0.00185	0.00448	CcSEcCtD
Metyrosine—Vomiting—Pentoxifylline—systemic scleroderma	0.00185	0.00447	CcSEcCtD
Metyrosine—Headache—Pentoxifylline—systemic scleroderma	0.00182	0.00441	CcSEcCtD
Metyrosine—Feeling abnormal—Captopril—systemic scleroderma	0.00182	0.00439	CcSEcCtD
Metyrosine—Gastrointestinal pain—Captopril—systemic scleroderma	0.0018	0.00436	CcSEcCtD
Metyrosine—Anxiety—Mycophenolic acid—systemic scleroderma	0.0018	0.00436	CcSEcCtD
Metyrosine—Asthenia—Mometasone—systemic scleroderma	0.0018	0.00435	CcSEcCtD
Metyrosine—Tremor—Lisinopril—systemic scleroderma	0.00179	0.00433	CcSEcCtD
Metyrosine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00178	0.0043	CcSEcCtD
Metyrosine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00177	0.00428	CcSEcCtD
Metyrosine—Anaemia—Lisinopril—systemic scleroderma	0.00177	0.00428	CcSEcCtD
Metyrosine—Confusional state—Mycophenolic acid—systemic scleroderma	0.00175	0.00423	CcSEcCtD
Metyrosine—Abdominal pain—Captopril—systemic scleroderma	0.00174	0.00421	CcSEcCtD
Metyrosine—Nausea—Pentoxifylline—systemic scleroderma	0.00173	0.00418	CcSEcCtD
Metyrosine—Diarrhoea—Mometasone—systemic scleroderma	0.00172	0.00415	CcSEcCtD
Metyrosine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.0017	0.0041	CcSEcCtD
Metyrosine—Insomnia—Leflunomide—systemic scleroderma	0.00164	0.00397	CcSEcCtD
Metyrosine—Anxiety—Lisinopril—systemic scleroderma	0.00162	0.00392	CcSEcCtD
Metyrosine—Vomiting—Mometasone—systemic scleroderma	0.0016	0.00386	CcSEcCtD
Metyrosine—Dry mouth—Lisinopril—systemic scleroderma	0.00159	0.00385	CcSEcCtD
Metyrosine—Feeling abnormal—Azathioprine—systemic scleroderma	0.00159	0.00383	CcSEcCtD
Metyrosine—Asthenia—Captopril—systemic scleroderma	0.00158	0.00382	CcSEcCtD
Metyrosine—Confusional state—Lisinopril—systemic scleroderma	0.00158	0.00381	CcSEcCtD
Metyrosine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00157	0.0038	CcSEcCtD
Metyrosine—Headache—Mometasone—systemic scleroderma	0.00157	0.0038	CcSEcCtD
Metyrosine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00157	0.0038	CcSEcCtD
Metyrosine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00157	0.00379	CcSEcCtD
Metyrosine—Fatigue—Leflunomide—systemic scleroderma	0.00157	0.00379	CcSEcCtD
Metyrosine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00155	0.00375	CcSEcCtD
Metyrosine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00153	0.0037	CcSEcCtD
Metyrosine—Abdominal pain—Azathioprine—systemic scleroderma	0.00152	0.00368	CcSEcCtD
Metyrosine—Diarrhoea—Captopril—systemic scleroderma	0.00151	0.00365	CcSEcCtD
Metyrosine—Erectile dysfunction—Prednisone—systemic scleroderma	0.0015	0.00363	CcSEcCtD
Metyrosine—Feeling abnormal—Leflunomide—systemic scleroderma	0.0015	0.00362	CcSEcCtD
Metyrosine—Fatigue—Mycophenolic acid—systemic scleroderma	0.0015	0.00361	CcSEcCtD
Metyrosine—Nausea—Mometasone—systemic scleroderma	0.00149	0.00361	CcSEcCtD
Metyrosine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00149	0.00359	CcSEcCtD
Metyrosine—Urticaria—Leflunomide—systemic scleroderma	0.00144	0.00349	CcSEcCtD
Metyrosine—Abdominal pain—Leflunomide—systemic scleroderma	0.00144	0.00347	CcSEcCtD
Metyrosine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00143	0.00345	CcSEcCtD
Metyrosine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00344	CcSEcCtD
Metyrosine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00142	0.00343	CcSEcCtD
Metyrosine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00142	0.00343	CcSEcCtD
Metyrosine—Insomnia—Lisinopril—systemic scleroderma	0.00141	0.00341	CcSEcCtD
Metyrosine—Vomiting—Captopril—systemic scleroderma	0.0014	0.00339	CcSEcCtD
Metyrosine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.0014	0.00337	CcSEcCtD
Metyrosine—Headache—Captopril—systemic scleroderma	0.00138	0.00334	CcSEcCtD
Metyrosine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00334	CcSEcCtD
Metyrosine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00137	0.00331	CcSEcCtD
Metyrosine—Eosinophilia—Methotrexate—systemic scleroderma	0.00135	0.00326	CcSEcCtD
Metyrosine—Fatigue—Lisinopril—systemic scleroderma	0.00135	0.00325	CcSEcCtD
Metyrosine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00324	CcSEcCtD
Metyrosine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00134	0.00324	CcSEcCtD
Metyrosine—Diarrhoea—Azathioprine—systemic scleroderma	0.00132	0.00318	CcSEcCtD
Metyrosine—Nausea—Captopril—systemic scleroderma	0.00131	0.00317	CcSEcCtD
Metyrosine—Asthenia—Leflunomide—systemic scleroderma	0.0013	0.00315	CcSEcCtD
Metyrosine—Hallucination—Prednisone—systemic scleroderma	0.0013	0.00314	CcSEcCtD
Metyrosine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00129	0.00311	CcSEcCtD
Metyrosine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00128	0.00309	CcSEcCtD
Metyrosine—Dysuria—Methotrexate—systemic scleroderma	0.00127	0.00308	CcSEcCtD
Metyrosine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00126	0.00303	CcSEcCtD
Metyrosine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00124	0.00301	CcSEcCtD
Metyrosine—Diarrhoea—Leflunomide—systemic scleroderma	0.00124	0.00301	CcSEcCtD
Metyrosine—Urticaria—Lisinopril—systemic scleroderma	0.00124	0.003	CcSEcCtD
Metyrosine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00299	CcSEcCtD
Metyrosine—Abdominal pain—Lisinopril—systemic scleroderma	0.00123	0.00298	CcSEcCtD
Metyrosine—Vomiting—Azathioprine—systemic scleroderma	0.00122	0.00296	CcSEcCtD
Metyrosine—Headache—Azathioprine—systemic scleroderma	0.00121	0.00291	CcSEcCtD
Metyrosine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00119	0.00287	CcSEcCtD
Metyrosine—Haematuria—Methotrexate—systemic scleroderma	0.00116	0.0028	CcSEcCtD
Metyrosine—Vomiting—Leflunomide—systemic scleroderma	0.00116	0.00279	CcSEcCtD
Metyrosine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00115	0.00278	CcSEcCtD
Metyrosine—Nausea—Azathioprine—systemic scleroderma	0.00114	0.00276	CcSEcCtD
Metyrosine—Headache—Leflunomide—systemic scleroderma	0.00114	0.00275	CcSEcCtD
Metyrosine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00273	CcSEcCtD
Metyrosine—Asthenia—Lisinopril—systemic scleroderma	0.00112	0.00271	CcSEcCtD
Metyrosine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00112	0.0027	CcSEcCtD
Metyrosine—Vomiting—Mycophenolic acid—systemic scleroderma	0.0011	0.00266	CcSEcCtD
Metyrosine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00263	CcSEcCtD
Metyrosine—Headache—Mycophenolic acid—systemic scleroderma	0.00109	0.00263	CcSEcCtD
Metyrosine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00261	CcSEcCtD
Metyrosine—Nausea—Leflunomide—systemic scleroderma	0.00108	0.00261	CcSEcCtD
Metyrosine—Diarrhoea—Lisinopril—systemic scleroderma	0.00107	0.00258	CcSEcCtD
Metyrosine—Anaemia—Prednisone—systemic scleroderma	0.00105	0.00254	CcSEcCtD
Metyrosine—Nausea—Mycophenolic acid—systemic scleroderma	0.00103	0.00249	CcSEcCtD
Metyrosine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00244	CcSEcCtD
Metyrosine—Vomiting—Lisinopril—systemic scleroderma	0.000993	0.0024	CcSEcCtD
Metyrosine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000982	0.00237	CcSEcCtD
Metyrosine—Headache—Lisinopril—systemic scleroderma	0.000979	0.00236	CcSEcCtD
Metyrosine—Anxiety—Prednisone—systemic scleroderma	0.000964	0.00233	CcSEcCtD
Metyrosine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000936	0.00226	CcSEcCtD
Metyrosine—Nausea—Lisinopril—systemic scleroderma	0.000928	0.00224	CcSEcCtD
Metyrosine—Anaemia—Methotrexate—systemic scleroderma	0.000878	0.00212	CcSEcCtD
Metyrosine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00087	0.0021	CcSEcCtD
Metyrosine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000857	0.00207	CcSEcCtD
Metyrosine—Insomnia—Prednisone—systemic scleroderma	0.000839	0.00203	CcSEcCtD
Metyrosine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000813	0.00196	CcSEcCtD
Metyrosine—Fatigue—Prednisone—systemic scleroderma	0.0008	0.00193	CcSEcCtD
Metyrosine—Confusional state—Methotrexate—systemic scleroderma	0.000782	0.00189	CcSEcCtD
Metyrosine—Feeling abnormal—Prednisone—systemic scleroderma	0.000764	0.00185	CcSEcCtD
Metyrosine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000759	0.00183	CcSEcCtD
Metyrosine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000759	0.00183	CcSEcCtD
Metyrosine—Urticaria—Prednisone—systemic scleroderma	0.000737	0.00178	CcSEcCtD
Metyrosine—Abdominal pain—Prednisone—systemic scleroderma	0.000733	0.00177	CcSEcCtD
Metyrosine—Insomnia—Methotrexate—systemic scleroderma	0.000701	0.00169	CcSEcCtD
Metyrosine—Hypersensitivity—Prednisone—systemic scleroderma	0.000684	0.00165	CcSEcCtD
Metyrosine—Fatigue—Methotrexate—systemic scleroderma	0.000668	0.00162	CcSEcCtD
Metyrosine—Asthenia—Prednisone—systemic scleroderma	0.000666	0.00161	CcSEcCtD
Metyrosine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000639	0.00154	CcSEcCtD
Metyrosine—Diarrhoea—Prednisone—systemic scleroderma	0.000635	0.00153	CcSEcCtD
Metyrosine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000634	0.00153	CcSEcCtD
Metyrosine—Urticaria—Methotrexate—systemic scleroderma	0.000616	0.00149	CcSEcCtD
Metyrosine—Abdominal pain—Methotrexate—systemic scleroderma	0.000613	0.00148	CcSEcCtD
Metyrosine—Vomiting—Prednisone—systemic scleroderma	0.00059	0.00143	CcSEcCtD
Metyrosine—Headache—Prednisone—systemic scleroderma	0.000581	0.0014	CcSEcCtD
Metyrosine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000571	0.00138	CcSEcCtD
Metyrosine—Asthenia—Methotrexate—systemic scleroderma	0.000556	0.00134	CcSEcCtD
Metyrosine—Nausea—Prednisone—systemic scleroderma	0.000551	0.00133	CcSEcCtD
Metyrosine—Diarrhoea—Methotrexate—systemic scleroderma	0.00053	0.00128	CcSEcCtD
Metyrosine—Vomiting—Methotrexate—systemic scleroderma	0.000493	0.00119	CcSEcCtD
Metyrosine—Headache—Methotrexate—systemic scleroderma	0.000486	0.00117	CcSEcCtD
Metyrosine—Nausea—Methotrexate—systemic scleroderma	0.000461	0.00111	CcSEcCtD
